Clinical Trials
20 trialsNCT05085002 2026-05-14
A Study of Lerociclib in Participants With Advanced Breast Cancer
EQRx International, Inc.
Phase 2 Terminated
NCT01517945 2026-04-24
Attention and Interpretation Modification (AIM) for Fear of Cancer Recurrence: An Intervention Development Study
Memorial Sloan Kettering Cancer Center
Active not recruiting
NCT03277638 2026-04-09
Laser Interstitial Thermotherapy (LITT) Combined With Checkpoint Inhibitor for Recurrent GBM (RGBM)
Case Comprehensive Cancer Center
Phase 1/2 Active not recruiting
NCT03292289 2026-03-17
QUALIPRO
Centre Oscar Lambret
Phase NA Completed
NCT07014618 2025-12-17
Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer
University of Oklahoma
Recruiting
NCT06640881 2025-10-01
REPEAT
Amsterdam UMC, location VUmc
Phase 2 Recruiting
NCT00532155 2025-09-10
VITAL
Sanofi
Phase 3 Completed
NCT05931068 2024-08-05
PRO-NRG
Academisch Ziekenhuis Maastricht
Recruiting
NCT06472063 2024-06-24
SNAC
San Luigi Gonzaga Hospital
Recruiting
NCT06450821 2024-06-10
PROSpECT-PRIOR-2-CHEMO: PRIOR Dental Intervention Before Chemo to Reduce Chemotherapy Complications
University of Leeds
Phase NA Not yet recruiting
NCT05616377 2022-11-15
CLTBME
Sun Yat-sen University
Unknown
NCT04842240 2021-04-13
PROM-Q
The Leeds Teaching Hospitals NHS Trust
Unknown
NCT03658265 2020-10-08
Effects of Exercise Training at Different Timeline on Shoulder Dysfunction After Breast Cancer Modified Radical Mastectomy
Wuhan University
Phase NA Completed
NCT01967095 2018-11-13
Low Dose Daily Erlotinib in Combination With High Dose Twice Weekly Erlotinib in Patients With EGFR-Mutant Lung Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT02800330 2018-08-02
REGORA
Erasmus Medical Center
Phase 4 Completed
NCT01797471 2017-12-21
Safety of LEAD Radiotherapy Plus Chemoradiation in Patients With Bulky Stage III Non-Small Cell Lung Cancer
University of Miami
Phase NA Terminated
NCT02075385 2017-06-28
Swallowing-1
Barretos Cancer Hospital
Phase 2 Completed
NCT01808638 2016-03-11
Atu027-I-02
Silence Therapeutics GmbH
Phase 1/2 Completed
NCT00210197 2013-07-26
EHC
Institut Bergonié
Completed
NCT00599703 2009-07-08
Language Function in Patients With Brain Tumors
Memorial Sloan Kettering Cancer Center
Completed